Back to Results
First PageMeta Content
Chemistry / Pharmaceuticals policy / Drug safety / Abbreviated New Drug Application / Generic drug / New Drug Application / Food and Drug Administration / Warfarin / IntelliPharmaCeutics / Pharmaceutical sciences / Pharmaceutical industry / Pharmacology


DEPARTMENT OF HEALId & HUMAN SERVICES Public Health Service &q
Add to Reading List

Document Date: 2003-10-24 18:01:00

Open Document

File Size: 193,02 KB

Share Result on Facebook

City

mg Tare Pharmaceuticals / Rockville / /

Company

MD 20857 Taro Pharmaceuticals / Gary J. Buehler / Gary Buehler / Bristol Myers Squibb / Taro Pharmaceuticals / /

Country

United States / /

Currency

pence / USD / /

Event

FDA Phase / /

IndustryTerm

listed reference drug product / drug product / above-referenced drug product / proposed drug product / listed drug product / /

Organization

Gary J. Buehler Director Office / Genetic Drugs Center for Drug Evaluation and Research / office of Generic Drugs / Food and Drug Administration / DEPARTMENT OF HEALId & HUMAN SERVICES Public Health Service / Division of Bioequivalence / Division of Bioequivalence GCF-l/K. DettelbacWL / /

Person

Avraham Yacobi / /

Position

Director / /

Product

Warfarin Sodium / Federal Food / Sodium / Warfarin Sodium Tablets / /

ProvinceOrState

Maryland / New York / /

SocialTag